{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:37:50Z","timestamp":1790645870482,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11064-026-04669-y","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T07:43:36Z","timestamp":1768895016000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["1,3,4-Oxadiazole Derivative: A Potential Anti-inflammatory and Antioxidant Agent in Experimental Autoimmune Encephalomyelitis"],"prefix":"10.1007","volume":"51","author":[{"given":"Syeda Rida","family":"Zainab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jehan Zeb","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syeda Anaa","family":"Batool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humaira","family":"Nadeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Khalid","family":"Tipu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humaira","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaheer","family":"Ul-Haq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem","family":"Irshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"issue":"1","key":"4669_CR1","first-page":"172791","volume":"2014","author":"S Bala","year":"2014","unstructured":"Bala S et al (2014) 1, 3, 4-Oxadiazole derivatives: synthesis, characterization, antimicrobial potential, and computational studies. Biomed Res Int 2014(1):172791","journal-title":"Biomed Res Int"},{"issue":"4","key":"4669_CR2","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1155\/2009\/698023","volume":"6","author":"N Bhardwaj","year":"2009","unstructured":"Bhardwaj N et al (2009) Syntheses, evaluation and characterization of some 1, 3, 4-oxadiazoles as antimicrobial agents. J Chem 6(4):1133\u20131138","journal-title":"J Chem"},{"issue":"8","key":"4669_CR3","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.2174\/0115701794265887231014061317","volume":"21","author":"T Chaudhary","year":"2023","unstructured":"Chaudhary T, Upadhyay PK, Kataria R (2023) Anti-inflammatory and antimicrobial potential of 1, 3, 4-oxadiazoles and its derivatives: a review. Curr Org Synth 21(8):1014\u20131020","journal-title":"Curr Org Synth"},{"issue":"8","key":"4669_CR4","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.2174\/0115701794265887231014061317","volume":"21","author":"T Chaudhary","year":"2024","unstructured":"Chaudhary T, Upadhyay PK, Kataria R (2024) Anti-inflammatory and antimicrobial potential of 1, 3, 4-oxadiazoles and its derivatives: a review. Curr Org Synth 21(8):1014\u20131020","journal-title":"Curr Org Synth"},{"key":"4669_CR5","doi-asserted-by":"publisher","first-page":"115071","DOI":"10.1016\/j.expneurol.2024.115071","volume":"384","author":"M Farzan","year":"2024","unstructured":"Farzan M et al (2024) The emerging role of the microglia triggering receptor expressed on myeloid cells (TREM) 2 in multiple sclerosis. Exp Neurol 384:115071","journal-title":"Exp Neurol"},{"issue":"8","key":"4669_CR6","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1001\/jama.2020.26858","volume":"325","author":"MP McGinley","year":"2021","unstructured":"McGinley MP, Goldschmidt CH, Rae-Grant AD (2021) Diagnosis and treatment of multiple sclerosis: a review. JAMA 325(8):765\u2013779","journal-title":"JAMA"},{"key":"4669_CR7","doi-asserted-by":"publisher","first-page":"1024058","DOI":"10.3389\/fnmol.2022.1024058","volume":"15","author":"RR Voskuhl","year":"2022","unstructured":"Voskuhl RR, MacKenzie-Graham A (2022) Chronic experimental autoimmune encephalomyelitis is an excellent model to study neuroaxonal degeneration in multiple sclerosis. Front Mol Neurosci 15:1024058","journal-title":"Front Mol Neurosci"},{"issue":"8","key":"4669_CR8","doi-asserted-by":"publisher","first-page":"e37297","DOI":"10.1097\/MD.0000000000037297","volume":"103","author":"M Haki","year":"2024","unstructured":"Haki M et al (2024) Review of multiple sclerosis: epidemiology, etiology, pathophysiology, and treatment. Medicine (Baltimore) 103(8):e37297","journal-title":"Medicine (Baltimore)"},{"key":"4669_CR9","first-page":"1","volume":"19","author":"N Ghasemi","year":"2017","unstructured":"Ghasemi N, Razavi S, Nikzad E (2017) Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy. Cell J 19:1\u201310","journal-title":"Cell J"},{"key":"4669_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-021-02344-z","volume":"21","author":"S Gustavsen","year":"2021","unstructured":"Gustavsen S et al (2021) The association of selected multiple sclerosis symptoms with disability and quality of life: a large Danish self-report survey. BMC Neurol 21:1\u201312","journal-title":"BMC Neurol"},{"key":"4669_CR11","unstructured":"Hauser, S.L. (1994), Multiple sclerosis and other demyelinating diseases. Harrison\u2019s principles of internal medicine, 2287."},{"key":"4669_CR12","doi-asserted-by":"publisher","first-page":"100019","DOI":"10.1016\/j.dscb.2021.100019","volume":"3","author":"S Upadhayay","year":"2021","unstructured":"Upadhayay S, Mehan S (2021) Targeting Nrf2\/HO-1 anti-oxidant signaling pathway in the progression of multiple sclerosis and influences on neurological dysfunctions. Brain Disord 3:100019","journal-title":"Brain Disord"},{"issue":"10","key":"4669_CR13","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.molmed.2013.08.001","volume":"19","author":"C Mc Guire","year":"2013","unstructured":"Mc Guire C et al (2013) Nuclear factor kappa B (NF-\u03baB) in multiple sclerosis pathology. Trends Mol Med 19(10):604\u2013613","journal-title":"Trends Mol Med"},{"key":"4669_CR14","doi-asserted-by":"publisher","first-page":"115998","DOI":"10.1016\/j.ejmech.2023.115998","volume":"264","author":"J Wang","year":"2024","unstructured":"Wang J et al (2024) Recent progress and applications of small molecule inhibitors of Keap1\u2013Nrf2 axis for neurodegenerative diseases. Eur J Med Chem 264:115998","journal-title":"Eur J Med Chem"},{"key":"4669_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3389\/fnmol.2016.00084","volume":"9","author":"SM Leibowitz","year":"2016","unstructured":"Leibowitz SM, Yan J (2016) NF-\u03baB pathways in the pathogenesis of multiple sclerosis and the therapeutic implications. Front Mol Neurosci 9:84","journal-title":"Front Mol Neurosci"},{"key":"4669_CR16","doi-asserted-by":"publisher","first-page":"101059","DOI":"10.1016\/j.redox.2018.11.017","volume":"21","author":"F Sivandzade","year":"2019","unstructured":"Sivandzade F et al (2019) NRF2 and NF-\u049bB interplay in cerebrovascular and neurodegenerative disorders: molecular mechanisms and possible therapeutic approaches. Redox Biol 21:101059","journal-title":"Redox Biol"},{"issue":"2","key":"4669_CR17","doi-asserted-by":"publisher","first-page":"e200190","DOI":"10.1212\/NXI.0000000000200190","volume":"11","author":"MD Binder","year":"2023","unstructured":"Binder MD et al (2023) HLA-DRB1* 15: 01 and the MERTK gene interact to selectively influence the profile of MERTK-expressing monocytes in both health and MS. Neurol Neuroimmunol Neuroinflam 11(2):e200190","journal-title":"Neurol Neuroimmunol Neuroinflam"},{"key":"4669_CR18","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.3389\/fimmu.2019.01564","volume":"10","author":"PS Rommer","year":"2019","unstructured":"Rommer PS et al (2019) Immunological aspects of approved MS therapeutics. Front Immunol 10:1564","journal-title":"Front Immunol"},{"issue":"6","key":"4669_CR19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1177\/2042098612462599","volume":"3","author":"D Ontaneda","year":"2012","unstructured":"Ontaneda D, Di Capua D (2012) Benefits versus risks of latest therapies in multiple sclerosis: a perspective review. Ther Adv Drug Saf 3(6):291\u2013303","journal-title":"Ther Adv Drug Saf"},{"key":"4669_CR20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/B978-0-444-52001-2.00008-X","volume":"122","author":"AP Robinson","year":"2014","unstructured":"Robinson AP et al (2014) The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment. Handb Clin Neurol 122:173\u2013189","journal-title":"Handb Clin Neurol"},{"issue":"12","key":"4669_CR21","first-page":"1632","volume":"24","author":"A Bukhari","year":"2021","unstructured":"Bukhari A et al (2021) Novel oxadiazole derivatives as potent inhibitors of \u03b1-amylase and \u03b1-glucosidase enzymes: synthesis, in vitro evaluation, and molecular docking studies. Iran J Basic Med Sci 24(12):1632","journal-title":"Iran J Basic Med Sci"},{"key":"4669_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-024-03474-0","author":"SR Zainab","year":"2024","unstructured":"Zainab SR et al (2024) Safety assessment of novel oxadiazole derivatives in acute and sub-acute toxicity studies. Naunyn Schmiedeberg\u2019s Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-024-03474-0","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"key":"4669_CR23","doi-asserted-by":"publisher","first-page":"105211","DOI":"10.1016\/j.neuint.2021.105211","volume":"151","author":"A Khan","year":"2021","unstructured":"Khan A et al (2021) Withametelin, a novel phytosterol, alleviates neurological symptoms in EAE mouse model of multiple sclerosis via modulation of Nrf2\/HO-1 and TLR4\/NF-\u03baB signaling. Neurochem Int 151:105211","journal-title":"Neurochem Int"},{"key":"4669_CR24","doi-asserted-by":"publisher","first-page":"8404","DOI":"10.1007\/s12035-016-0333-1","volume":"54","author":"Q-C Kan","year":"2017","unstructured":"Kan Q-C et al (2017) Matrine treatment blocks NogoA-induced neural inhibitory signaling pathway in ongoing experimental autoimmune encephalomyelitis. Mol Neurobiol 54:8404\u20138418","journal-title":"Mol Neurobiol"},{"issue":"1","key":"4669_CR25","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1038\/s41467-018-04049-3","volume":"9","author":"R Dhandapani","year":"2018","unstructured":"Dhandapani R et al (2018) Control of mechanical pain hypersensitivity in mice through ligand-targeted photoablation of TrkB-positive sensory neurons. Nat Commun 9(1):1640","journal-title":"Nat Commun"},{"key":"4669_CR26","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fphar.2018.00140","volume":"9","author":"S Khalid","year":"2018","unstructured":"Khalid S et al (2018) Antihyperalgesic properties of honokiol in inflammatory pain models by targeting of NF-\u03baB and Nrf2 signaling. Front Pharmacol 9:140","journal-title":"Front Pharmacol"},{"issue":"7","key":"4669_CR27","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jpain.2009.01.325","volume":"10","author":"I Yalcin","year":"2009","unstructured":"Yalcin I et al (2009) Differentiating thermal allodynia and hyperalgesia using dynamic hot and cold plate in rodents. J Pain 10(7):767\u2013773","journal-title":"J Pain"},{"key":"4669_CR28","first-page":"2610","volume":"76","author":"RM Deacon","year":"2013","unstructured":"Deacon RM (2013) Measuring the strength of mice. J Vis Exp 76:2610","journal-title":"J Vis Exp"},{"key":"4669_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-1-4939-8994-2_9","volume-title":"Pre-clinical models: techniques and protocols","author":"A-K Kraeuter","year":"2019","unstructured":"Kraeuter A-K, Guest PC, Sarnyai Z (2019) The open field test for measuring locomotor activity and anxiety-like behavior. Pre-clinical models: techniques and protocols. Springer, Cham, pp 99\u2013103"},{"issue":"5","key":"4669_CR30","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1007\/s00210-023-02814-w","volume":"397","author":"MU Mazhar","year":"2024","unstructured":"Mazhar MU et al (2024) Immunostimulant, hepatoprotective, and nephroprotective potential of Bacillus subtilis (NMCC-path-14) in comparison to dexamethasone in alleviating CFA-induced arthritis. Naunyn Schmiedebergs Arch Pharmacol 397(5):3275\u20133299","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"4669_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0304-4165(79)90289-7","volume":"582","author":"MS Moron","year":"1979","unstructured":"Moron MS, Depierre JW, Mannervik B (1979) Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochimica et biophysica acta (BBA)-general subjects 582(1):67\u201378","journal-title":"Biochimica et biophysica acta (BBA)-general subjects"},{"issue":"2","key":"4669_CR32","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95(2):351\u2013358","journal-title":"Anal Biochem"},{"key":"4669_CR33","first-page":"149","volume-title":"Methods in Cell Biology","author":"P Ghosh","year":"2024","unstructured":"Ghosh P et al (2024) Estimating nitric oxide (NO) from MDSCs by Griess method. Methods in Cell Biology. Elsevier, pp 149\u2013158"},{"key":"4669_CR34","first-page":"661","volume-title":"Protein Domain Prediction","author":"SC Peter","year":"2019","unstructured":"Peter SC et al (2019) Encyclopedia of bioinformatics and computational biology. In: Ranganathan S, Grib-skov M, Nakai K, Sch\u00f6nbach C (eds) Protein Domain Prediction. Elsevier, Amsterdam, pp 661\u2013676"},{"key":"4669_CR35","volume-title":"Unravelling Molecular Docking-From Theory to Practice","author":"N Mathur","year":"2024","unstructured":"Mathur N et al (2024) In silico docking: protocols for computational exploration of molecular interactions. Unravelling Molecular Docking-From Theory to Practice. IntechOpen, London"},{"issue":"5\u20136","key":"4669_CR36","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<490::AID-JCC1>3.0.CO;2-P","volume":"17","author":"TA Halgren","year":"1996","unstructured":"Halgren TA (1996) Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J Comput Chem 17(5\u20136):490\u2013519","journal-title":"J Comput Chem"},{"issue":"3","key":"4669_CR37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/qsar.19860050305","volume":"5","author":"I Motoc","year":"1986","unstructured":"Motoc I et al (1986) Three\u2010dimensional quantitative structure\u2010activity relationships i. General approach to the pharmacophore model validation. Quant Struct Act Relat 5(3):99\u2013105","journal-title":"Quant Struct Act Relat"},{"key":"4669_CR38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ et al (2015) GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1:19\u201325","journal-title":"SoftwareX"},{"key":"4669_CR39","first-page":"1","volume":"5","author":"AW da Sousa Silva","year":"2012","unstructured":"da Sousa Silva AW, Vranken WF (2012) ACPYPE-Antechamber python parser interface. BMC Res Notes 5:1\u20138","journal-title":"BMC Res Notes"},{"issue":"2","key":"4669_CR40","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen WL et al (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79(2):926\u2013935","journal-title":"J Chem Phys"},{"issue":"7","key":"4669_CR41","doi-asserted-by":"publisher","first-page":"075503","DOI":"10.1103\/PhysRevLett.90.075503","volume":"90","author":"R Marto\u0148\u00e1k","year":"2003","unstructured":"Marto\u0148\u00e1k R, Laio A, Parrinello M (2003) Predicting crystal structures: the Parrinello-Rahman method revisited. Phys Rev Lett 90(7):075503","journal-title":"Phys Rev Lett"},{"key":"4669_CR42","doi-asserted-by":"publisher","first-page":"112896","DOI":"10.1016\/j.bbr.2020.112896","volume":"396","author":"AJ Kwilasz","year":"2021","unstructured":"Kwilasz AJ et al (2021) Experimental autoimmune encephalopathy (EAE)-induced hippocampal neuroinflammation and memory deficits are prevented with the non-opioid TLR2\/TLR4 antagonist (+)-naltrexone. Behav Brain Res 396:112896","journal-title":"Behav Brain Res"},{"issue":"2","key":"4669_CR43","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1212\/WNL.62.2.226","volume":"62","author":"JC Bot","year":"2004","unstructured":"Bot JC et al (2004) Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination. Neurology 62(2):226\u2013233","journal-title":"Neurology"},{"issue":"3","key":"4669_CR44","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00415-004-0348-9","volume":"251","author":"Y Gilgun-Sherki","year":"2004","unstructured":"Gilgun-Sherki Y, Melamed E, Offen D (2004) The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J Neurol 251(3):261\u2013268","journal-title":"J Neurol"},{"key":"4669_CR45","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.expneurol.2015.11.010","volume":"277","author":"K Ohl","year":"2016","unstructured":"Ohl K, Tenbrock K, Kipp M (2016) Oxidative stress in multiple sclerosis: central and peripheral mode of action. Exp Neurol 277:58\u201367","journal-title":"Exp Neurol"},{"issue":"12","key":"4669_CR46","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.freeradbiomed.2008.09.023","volume":"45","author":"J Van Horssen","year":"2008","unstructured":"Van Horssen J et al (2008) Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression. Free Radical Biol Med 45(12):1729\u20131737","journal-title":"Free Radical Biol Med"},{"issue":"7","key":"4669_CR47","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1093\/brain\/awr128","volume":"134","author":"L Haider","year":"2011","unstructured":"Haider L et al (2011) Oxidative damage in multiple sclerosis lesions. Brain 134(7):1914\u20131924","journal-title":"Brain"},{"issue":"10","key":"4669_CR48","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.3390\/jcm8101659","volume":"8","author":"RI Teleanu","year":"2019","unstructured":"Teleanu RI et al (2019) Antioxidant therapies for neuroprotection\u2014a review. J Clin Med 8(10):1659","journal-title":"J Clin Med"},{"key":"4669_CR49","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.neuroscience.2023.08.005","volume":"529","author":"BM Escribano","year":"2023","unstructured":"Escribano BM et al (2023) Effect of the combination of different therapies on oxidative stress in the experimental model of multiple sclerosis. Neuroscience 529:116\u2013128","journal-title":"Neuroscience"},{"issue":"1","key":"4669_CR50","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13024-024-00742-8","volume":"19","author":"O Zveik","year":"2024","unstructured":"Zveik O et al (2024) The interplay of inflammation and remyelination: rethinking MS treatment with a focus on oligodendrocyte progenitor cells. Mol Neurodegener 19(1):53","journal-title":"Mol Neurodegener"},{"key":"4669_CR51","first-page":"72","volume":"14","author":"A Singh","year":"2025","unstructured":"Singh A, Kabra A, Singh L (2025) Role of Formononetin (Isoflavone) in Parkinson\u2019s disease. Lett Appl NanoBiosci 14:72","journal-title":"Lett Appl NanoBiosci"},{"key":"4669_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-00549-7_9","author":"MK Racke","year":"2009","unstructured":"Racke MK, Drew PD (2009) Toll-like receptors in multiple sclerosis. Toll like Recept Roles Infect Neuropathol. https:\/\/doi.org\/10.1007\/978-3-642-00549-7_9","journal-title":"Toll like Recept Roles Infect Neuropathol"},{"issue":"1","key":"4669_CR53","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s43440-024-00672-8","volume":"77","author":"A Singh","year":"2025","unstructured":"Singh A, Singh L (2025) Acyclic sesquiterpenes nerolidol and farnesol: mechanistic insights into their neuroprotective potential. Pharmacol Rep 77(1):31\u201342","journal-title":"Pharmacol Rep"},{"key":"4669_CR54","doi-asserted-by":"publisher","DOI":"10.1007\/s11062-025-09967-9","author":"D Dalal","year":"2025","unstructured":"Dalal D, Singh L, Singh A (2025) Desmethylglycitein attenuates scopolamine-induced cognitive deficits via Nrf-2 activation and IL-1\u03b2 suppression. Neurophysiology. https:\/\/doi.org\/10.1007\/s11062-025-09967-9","journal-title":"Neurophysiology"},{"issue":"3","key":"4669_CR55","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S0896-6273(00)81107-1","volume":"24","author":"L Steinman","year":"1999","unstructured":"Steinman L (1999) Assessment of animal models for MS and demyelinating disease in the design of rational therapy. Neuron 24(3):511\u2013514","journal-title":"Neuron"},{"issue":"4","key":"4669_CR56","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/(SICI)1097-4547(19960815)45:4<322::AID-JNR1>3.0.CO;2-B","volume":"45","author":"V Navikas","year":"1996","unstructured":"Navikas V, Link H (1996) Cytokines and the pathogenesis of multiple sclerosis. J Neurosci Res 45(4):322\u2013333","journal-title":"J Neurosci Res"},{"issue":"4","key":"4669_CR57","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.neuron.2018.01.021","volume":"97","author":"C Baecher-Allan","year":"2018","unstructured":"Baecher-Allan C, Kaskow BJ, Weiner HL (2018) Multiple sclerosis: mechanisms and immunotherapy. Neuron 97(4):742\u2013768","journal-title":"Neuron"},{"issue":"2","key":"4669_CR58","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.molmed.2018.11.005","volume":"25","author":"S Voet","year":"2019","unstructured":"Voet S, Prinz M, van Loo G (2019) Microglia in central nervous system inflammation and multiple sclerosis pathology. Trends Mol Med 25(2):112\u2013123","journal-title":"Trends Mol Med"},{"key":"4669_CR59","doi-asserted-by":"publisher","first-page":"503650","DOI":"10.1016\/j.mrgentox.2023.503650","volume":"889","author":"S Attia","year":"2023","unstructured":"Attia S et al (2023) The small molecule Erk1\/2 signaling pathway inhibitor PD98059 improves DNA repair in an experimental autoimmune encephalomyelitis SJL\/J mouse model of multiple sclerosis. Mutat Res Genet Toxicol Environ Mutagen 889:503650","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"key":"4669_CR60","doi-asserted-by":"crossref","unstructured":"Filipek, B and T Poplawski (2024) Elevated Level of DNA Damage and Impaired Repair of DNA Oxidative Damage in Multiple Sclerosis Patients (P7\u20136.010). in Neurology. AAN Enterprises","DOI":"10.1212\/WNL.0000000000208336"},{"key":"4669_CR61","doi-asserted-by":"publisher","first-page":"640778","DOI":"10.3389\/fimmu.2021.640778","volume":"12","author":"M Dou","year":"2021","unstructured":"Dou M et al (2021) Illumination of molecular pathways in multiple sclerosis lesions and the immune mechanism of matrine treatment in EAE, a mouse model of MS. Front Immunol 12:640778","journal-title":"Front Immunol"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-026-04669-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-026-04669-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-026-04669-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T11:05:21Z","timestamp":1772622321000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-026-04669-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4669"],"URL":"https:\/\/doi.org\/10.1007\/s11064-026-04669-y","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"assertion":[{"value":"22 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"All research procedures were carefully carried out following the guidelines of Quaid-i-Azam University for animal care and use. The bioethical committee thoroughly approved the methodology, ensuring the ethical treatment of the animals involved in the study (Approval No.#BEC-FBS-QAU2024-668). This study does not involve any clinical trials.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"50"}}